论文部分内容阅读
自体造血干细胞移植（ＡＨＳＣＴ）系采集自体造血干细胞存贮体外，待患者接受大剂量化疗或化、放疗后再移植入患者体内，使其恢复造血功能。按造血干细胞来源不同，ＡＨＳＣＴ可分为自体骨髓移植（ＡＢＭＴ）和自体外周血干细胞移植（ＡＰＢＳＣＴ）。近年来，ＡＨＳＣＴ已成
The Autologous Hematopoietic Stem Cell Transplantation (AHSCT) system collects autologous hematopoietic stem cell (HSC) cells in vitro and waits for patients receiving high-dose chemotherapy or radiotherapy to be transplanted into the patient’s body to restore hematopoietic function. According to different sources of hematopoietic stem cells, AHSCT can be divided into autologous bone marrow transplantation (ABMT) and autologous peripheral blood stem cell transplantation (APBSCT). In recent years, AHSCT has become